Pediatric Cancer: US FDA Will Take ‘Rational’ Approach To Requiring Combination Studies

 
• By Sue Sutter
  
blue-puzzle-pieces
Figuring out how different agents fit together to treat pediatric cancers will require prioritization. • Source: Shutterstock

More from Clinical Trials

More from R&D